Vnitr Lek 2010, 56(Suppl 1):31-38

Dysplastic changes in megakaryopoiesis according to WHO classification 2008

A. Buliková*, J. Kissová, M. Antoąová, L. Antoąová, I. Trnavská
Oddělení klinické hematologie FN Brno, pracoviątě Bohunice, přednosta prof. MUDr. Miroslav Penka, CSc.

Megakaryocytic dysplasia is frequent finding not only in patients with diagnose of myelodysplastic syndromes but also in wide spectrum of the other clinic situations. In this paper authors summarized the possibilities and also limitations of peripheral blood and bone marrow smears evaluation in the process of diagnose of myelodysplastic syndrome. Usual megakaryopoiesis with respect of morphology point of view is also mentioned during introduce of the paper.

Keywords: megakaryopoiesis; dysplastic changes; myelodysplastic syndrome

Received: March 24, 2010; Published: February 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Buliková A, Kissová J, Antoąová M, Antoąová L, Trnavská I. Dysplastic changes in megakaryopoiesis according to WHO classification 2008. Vnitr Lek. 2010;56(Supplementum 1):31-38.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Chang Y, Bluteau D, Debili N et al. From hematopoietic stem cells to platelets. J Throm Haemost 2007; 5 (Suppl 1): 318-327. Go to original source... Go to PubMed...
    2. Fosberg EC, Serwold T, Kogan S et al. New evidence supporting megakarocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors. Cell 2006; 126: 415-426. Go to original source... Go to PubMed...
    3. Bain BJ, Clark DM, Wilkins BS. Bone marrow pathology. 4th ed. Wiley-Blackwell 2010: 20-26. Go to original source...
    4. Bessis M. Blood smears reinterpreted (transl. Brechner G). Heidelberg Springer-Verlag Berlin 1977: 129-144. Go to original source...
    5. Roy L, Coullin P, Virat N et al. Asymmetrical segregation of chromosomes with a normal metaphase/anaphase checkpoint in polyploid megakaryocytes. Blood 2001; 97: 2238-2247. Go to original source... Go to PubMed...
    6. Mattia G, Vulcano F, Milazzo L et al. Different ploidity levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 2002; 99: 888-897. Go to original source... Go to PubMed...
    7. Italiano JE, Patel-Hett S, Hartwig JH. Mechanics of proplatelet elaboration. J Thromb Haemost 2007; 5 (Suppl 1): 18-23. Go to original source... Go to PubMed...
    8. Pecka M, Malý J, Fátorová I et al. Nové pohledy na vývoj megakaryopoézy a trombopoézy. Trans Hemat dnes 2008; 4 (Suppl 1): 21-22.
    9. Bolton-Maggs PHB, Chalmers EA, Collins PW et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006; 135: 603-633. Go to original source... Go to PubMed...
    10. Brunning RD, Orazi A, Germing U et al. Myelodysplastic syndromes/neoplasms, overwiew. In: Swerdlow SH, Campo E, Harris NL et al (eds). WHO classification of tumours of haematopoietic and lymphoid tissues. Geneva: WHO Press 2008: 88-93.
    11. Bennett JM, Catovsky D, Daniel MT et al. Proposal for the classification of the acute leukaemias (FAB cooperative group). Br J Haematol 1976; 33: 451-458. Go to original source... Go to PubMed...
    12. Brunning RD, Bennett JM, Flandrin G et al. Myelodysplastic syndromes: Introduction. In: Jaffe ES, Harris NL, Stein H et al (eds). World Health Organization classification of tumours: Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: ICAC Press 2001: 63-67.
    13. van de Loosdrecht AA, Westers TM, Westra AH et al. Identification of district progrostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood 2008; 111: 1067-1077. Go to original source... Go to PubMed...
    14. Mufti GJ, Bennett JM, Goasguent J et al. Diagnosis and classification of myelodysplastic syndrome: International working group in morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica 2008; 93: 1712-1717. Go to original source... Go to PubMed...
    15. van de Loosdrecht AA, Alhan C, Béne MCh et al. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndrome. Haematologica 2009; 94: 1124-1134. Go to original source... Go to PubMed...
    16. Steensma DP. The changing classification of myelodysplastic syndromes: what's in a name? Hematology (Am Soc Hematol Educ Program) 2009: 645-655. Go to original source... Go to PubMed...
    17. Verdiman JW, Brunning RD, Arber DA et al. Introduction and overview of the classification of the myeloid neoplasms. In: Swerdlow SH, Campo E, Harris NL et al. (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues. Geneva: WHO Press 2008: 18-30.
    18. Bain BJ, Clark DM, Wilkins BS. Bone marrow pathology. 4th ed. Wiley-Blackwell 2010: 208-228. Go to original source...
    19. Kačírková P, Campr V. Hematoonkologický atlas krve a kostní dřeně. Praha: Grada Publishing 2007: 55-88.
    20. Hasserrjian RP, Le Beau MM, List AF et al. Myelodysplastic syndrome with isolated del (5q). In: Swerdlow SH, Campo E, Harris NL et al (eds). WHO classification of tumours of haematopoietic and lymphoid tissues. Geneva: WHO Press 2008: 102-103.
    21. Brunning RD, Hasserjian RP, Porwizt A et al. Refractory cytopenia with unilineage dysplasia. In: Swerdlow SH, Campo E, Harris NL et al (eds). WHO classification of tumours of haematopoietic and lymphoid tissues. Geneva: WHO Press 2008: 94-97.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.